Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Impact Proteomics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Impact Proteomics

Impact Proteomics

Pre-Seed

Impact Proteomics: Your one-stop solution for protein, peptide, and proteome sample preparation.

HQ
Pittsburgh, PA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Impact Proteomics, founded with the mission to revolutionize protein, peptide, and proteome sample preparation, offers comprehensive solutions for any starting sample and final application. The company focuses on providing advanced technologies such as their patented ProMTag and the IP-to-MS platform, which is the first unbiased antigen discovery platform. Their services cater to researchers and institutions in the fields of proteomics and multiomics, aiming to drive innovation in immune profiling and other related areas.

Notable figures associated with Impact Proteomics include leading scientists and industry experts who have contributed to its technological advancements. The company has secured investments from prominent venture capital firms specializing in biotech innovations. Key achievements include the successful development and deployment of their IP-to-MS platform, which has significantly impacted the field of antigen discovery. Overall, Impact Proteomics has established itself as a pivotal player in advancing proteomic research and applications.

Impact Proteomics - Similar Companies

Integrated Protein Technologies logo

Integrated Protein Technologies

iptinc.com

ProteoWise logo

ProteoWise

proteowise.com

NEO Proteomics logo

NEO Proteomics

neoproteomics.net

Antigen Discovery logo

Antigen Discovery

Proteios Technology logo

Proteios Technology

proteios.com

Applied Proteomics logo

Applied Proteomics

Protea Biosciences logo

Protea Biosciences

proteabio.com

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

Seer logo

Seer

seer.bio

Immuto Scientific logo

Immuto Scientific

Key Proteo logo

Key Proteo

keyproteo.com

Protein Dynamic Solutions logo

Protein Dynamic Solutions

pdsbio.com

Ionpath logo

Ionpath

ImmPro logo

ImmPro

immpro.com

Panome Bio logo

Panome Bio

panomebio.com

Impact Proteomics - Quick Facts

Who are Impact Proteomics' competitors?

Companies similar to Impact Proteomics include Integrated Protein Technologies, ProteoWise, NEO Proteomics and Antigen Discovery.

When was Impact Proteomics founded?

Impact Proteomics was founded in 2018.

Where is Impact Proteomics' headquarters located?

Impact Proteomics' headquarters is located in Pittsburgh, PA, US.

When was Impact Proteomics' last funding round?

Impact Proteomics' most recent funding round was for $999.7k (USD) in April 2021.

How much has Impact Proteomics raised to-date?

As of Apr 7, 2021, Impact Proteomics has raised a total of $1.3M (USD).

How many employees does Impact Proteomics have?

Impact Proteomics has 8 employees as of Feb 5, 2024.

Impact Proteomics - Classification

Industry
  • Professional Service Companies
Technology
  • Proteomics
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Sample Preparation
Tags
  • Biotech
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research